Cocrystal pharma to present at the h.c. wainwright global life sciences virtual conference [updated]

Bothell, wash., march 02, 2021 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp), (“cocrystal” or the “company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the sars-cov-2 virus, hepatitis c viruses and noroviruses, announces that management will present a company overview and hold virtual investor meetings at the h.c. wainwright global life sciences virtual conference being held march 9-10, 2021.
COCP Ratings Summary
COCP Quant Ranking